Semaglutide and Intermittent Fasting: Quick Guide to Fat Loss
Integrating Semaglutide with Intermittent Fasting: A Synergistic Approach to Fat Loss The confluence of pharmacotherapy and dietary strategies is reshaping the landscape of obesity management. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered FDA approval for weight loss due to its potent appetite-suppressing and metabolic regulatory effects. When combined with intermittent fasting—a pattern of … Read more